Clinical Trial Update: Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) [Phase 1]

View source ↗

Summary

Phase 1 results update for the PASCAL pulsed electromagnetic field platform as a selective treatment approach for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PASCAL pulsed electromagnetic field platform

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED